FDA Inspection
Catalent Greenville IncCatalent Greenville Inc – FDA Inspection, Jul 12, 2019
Record Details
This FDA Inspection record concerns Catalent Greenville Inc, with an inspection on July 12, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Claire M. Minden (Investigator)
- Lakeesha M. Sifontes (Issuing Officer)
View Company Profile
ID · be367675-334c-4c75-955e-aad4e684ecfe
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1097051
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Catalent Greenville Inc
12| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2025 | VAI | Atlanta District Office | Drug Quality Assurance |
| January 31, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 24, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Catalent Greenville Inc
- FDA Inspection 1267356 - 2025-10-24
- FDA Inspection 1231042 - 2024-01-31
- FDA Inspection 1065149 - 2018-08-24
- FDA Inspection 1019260 - 2017-04-13
- FDA Inspection 983236 - 2016-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.